"Fistula"

Doppler ultrasound surveillance of recently formed haemodialysis arteriovenous fistula: the SONAR observational cohort study Doppler ultrasound surveillance of recently formed haemodialysis arteriovenous fistula: the SONAR observational cohort study * Text only * * Home * Journals * * Other NIHR research * * For authors * For reviewers * About * Policies * * Accessibility * Journals LibraryNHS

Oesophageal atresia and tracheo-oesophageal fistula Oesophageal atresia and tracheo-oesophageal fistula - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * English (US)EnglishPortuguês中文 * Log in * Personal account * Access through your institution(Open Athens) * Subscribe * Access through your institution * Log in * English (US)EnglishPortuguês中文 * HelpFAQsHow do I get access?Contact us When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance. OKCancelOesophageal atresia and tracheo-oesophageal fistula Menu Close * Overview  * Theory  * Diagnosis  * Management  * Follow up  * Resources  * Overview * Summary * Theory

Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access Interventional procedures guidance Published: 27 October 2021 www.nice.org.uk/guidance/ipg710 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration fistula creation for haemodialysis access raises no major safety concerns. However, evidence on its efficacy is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page. 1.2 Clinicians wanting to do

Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Postoperative pancreatic fistula (POPF) is one of the most frequent and potentially life-threatening complications following pancreatic surgery. Fibrin sealants have been used in some centres to reduce POPF rate. However, the use of fibrin sealant during pancreatic surgery is controversial

Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula Copyright © The American Society of Colon & Rectal Surgeons, Inc. Unauthorized reproduction of this article is prohibited.964DISEASES OF THE COLON & RECTUM VOLUME 65: 8 (2022)CLINICAL PRACTICE GUIDELINESThe American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anorectal Abscess , Fistula-in-Ano, and Rectovaginal FistulaWolfgang B. Gaertner, M.D., M.Sc.1 • Pamela L. Burgess, M.D.2 Jennifer S. Davids, M.D.3 • Amy L. Lightner, M.D.4 • Benjamin D. Shogan, M.D.5 Mark Y. Sun, M.D.1 • Scott R. Steele, M.D., M.B.A.4 • Ian M. Paquette, M.D.6 Daniel L. Feingold, M.D.7 On behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons1

Perspectives and Experiences Regarding the Creation of Arteriovenous Fistulas for Hemodialysis Access: A Rapid Qualitative Review Return to Article DetailsPerspectives and Experiences Regarding the Creation of Arteriovenous Fistulas for Hemodialysis Access: A Rapid Qualitative Review

Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access. The failure of arteriovenous fistulas (AVF) to mature is a major problem in patients with kidney failure who require haemodialysis (HD). Preoperative planning is an important factor in increasing functional AVF. Upper limb exercise has been recommended to gain AVF maturation. Studies

Dialysis Fistula Malfunction New 2023 ACR Appropriateness Criteria® 1 Dialysis Fistula Malfunction American College of Radiology ACR Appropriateness Criteria®Dialysis Fistula Malfunction Variant 1: Suspected dysfunction of upper or lower extremity hemodialysis access (ie, arteriovenous fistula or graft) suggested by an abnormal clinical indicator or hemodynamic indicator (ie Variant 2: Suspected dysfunction of the upper or lower extremity hemodialysis access (ie, arteriovenous fistula or graft) suggested by an abnormal clinical indicator or hemodynamic indicator (ie, reduction in dialysis vascular access blood flow rate or kinetics). Treatment and procedures. Procedure Appropriateness Category US duplex Doppler hemodialysis access area of interest Usually

Dialysis Fistula Malfunction New 2023 ACR Appropriateness Criteria® 1 Dialysis Fistula Malfunction American College of Radiology ACR Appropriateness Criteria®Dialysis Fistula Malfunction Variant 1: Suspected dysfunction of upper or lower extremity hemodialysis access (ie, arteriovenous fistula or graft) suggested by an abnormal clinical indicator or hemodynamic indicator (ie Variant 2: Suspected dysfunction of the upper or lower extremity hemodialysis access (ie, arteriovenous fistula or graft) suggested by an abnormal clinical indicator or hemodynamic indicator (ie, reduction in dialysis vascular access blood flow rate or kinetics). Treatment and procedures. Procedure Appropriateness Category US duplex Doppler hemodialysis access area of interest Usually

Endoscopic ablation for an anal fistula Endoscopic ablation for an anal fistula Interventional procedures guidance Published: 17 April 2019 www.nice.org.uk/guidance/ipg645 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Current evidence on endoscopic ablation for an anal fistula raises no major © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 1 of4safety concerns and the evidence on efficacy is adequate in quality and quantity. Therefore

Collagen paste for closing an anal fistula Collagen paste for closing an anal fistula Interventional procedures guidance Published: 29 May 2019 www.nice.org.uk/guidance/ipg648 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page. 1.2 Further research should report details of patient selection, the type of fistula treated, how the internal fistula opening was closed, and long-term outcomes including recurrence and the need for reoperation. 2 2 The condition, current treatments

Bioprosthetic plug insertion for anal fistula Bioprosthetic plug insertion for anal fistula Interventional procedures guidance Published: 25 September 2019 www.nice.org.uk/guidance/ipg662 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals the environmental impact of implementing NICE recommendations wherever possible. This guidance replaces IPG410. © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 1 of41 1 Recommendations Recommendations 1.1 Current evidence on the safety and efficacy of bioprosthetic plug insertion for anal fistula is adequate to support the use

Radially emitting laser fibre treatment of an anal fistula Radially emitting laser fibre treatment of an anal fistula Interventional procedures guidance Published: 13 March 2019 www.nice.org.uk/guidance/ipg644 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Current evidence on the safety and efficacy of radially emitting laser fibre © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 1 of5treatment of an anal fistula is limited in quantity

What is the clinical presentation of atrioesophageal fistula following atrial fibrillation ablation? Chiefs’ Inquiry Corner – 4/18/22 – Clinical Correlations Clinical Correlations * AboutAboutAwardsPeer Review * CategoriesBedside RoundsChiefs' Inquiry CornerCORE IM PodcastDiseases 2.0EthicsEvolution and MedicineGamechanger?Healthcare PolicyHotSpotsMystery QuizMyths quick-and-easy, evidence-based answers to interesting questions posed by house staff, both in their clinics and on the wards.Click to toggle the answers!Tisch-Kimmel Inpatient:What is the clinical presentation of atrioesophageal fistula following atrial fibrillation ablation? An atrioesophageal fistula is a very rare (incidence rate of 0.03%-0.08%, although this may be an underestimate due

Endovascular Therapy for the Treatment of Cerebrospinal Fluid Venous Fistulas Skip to main contentAboutCollaboration/OutreachPatient/CommunityCareersContactMy CADTHFRReportsResourcesProvide InputSubmit a RequestNews & EventsWhat Does The Evidence Say About...SearchBreadcrumbHome Endovascular Therapy for the Treatment of Cerebrospinal Fluid Venous FistulasCopied to clipboardEndovascular Therapy for the Treatment of Cerebrospinal Fluid Venous Fistulas( Last Updated : November 14, 2022)Project Status:CompletedProject Line:Reference ListProject Sub Line:Summary of AbstractsProject Number:RB1642-000Effective finish date:November 16, 2022DetailsQuestionWhat is the clinical effectiveness of endovascular therapy for the treatment of patients with cerebrospinal fluid venous fistulas compared to other surgical

Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Postoperative pancreatic fistula is one of the most frequent and potentially life-threatening complications following pancreatic resections. Fibrin sealants have been used in some centers to reduce postoperative pancreatic fistula. However, the use of fibrin sealants during pancreatic surgery is controversial. This is an update of a Cochrane Review last published in 2018. To assess the safety, effectiveness, and potential adverse effects of fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. We searched trial registers and the following biomedical databases: the Cochrane Library (2019, Issue 2), MEDLINE (1946 to 13 March2019), Embase (1980 to 11 March

Utility of T2-weighted MRI and contrast-enhanced MRA in locating the fistula level of spinal arteriovenous fistula. To investigate the value of routine T2-weighted magnetic resonance imaging (MRI) and contrast-enhanced magnetic resonance angiography (CE-MRA) sequences in locating the fistula level of spinal arteriovenous fistula (SAVF). Retrospectively analyzed the radiological findings of patients with SAVF diagnosed by surgery from May 2018 to September 2024. All patients completed spinal CE-MRA and routine T2-weighted MRI. The imaging manifestations of SAVF lesions on CE-MRA and MRI were summarized and analyzed. We enrolled 40 cases with SAVF (average age 58.1 years old, 85.0% male). The majority of fistulas were located in the thoracic (60.0%), followed by the lumbar (27.5

Diagnosing Crohn's Disease in Presumed Cryptoglandular Perianal Fistulas: An Expert Delphi Consensus on Early Identification of Patients at Risk of Crohn's Disease in Perianal Fistulas (PREFAB). The aim of this Delphi study was to reach consensus on a new clinical decision tool to help identify or exclude Crohn's disease (CD) in patients with perianal fistula(s) (PAF). A panel of international patients for a colonoscopy in case of elevated FCP levels (≥150mcg/g) and/or in case of one clinical major criterion (defined as: unintentional weight loss, unexplained diarrhea, PSC, UC, >1 internal fistula openings, fistula involving other organs (vagina/bladder), recurrent fistulation (after initial healing), proctitis and anal stenosis). Also, clinical (fistula-)characteristics that warrant raised

Protocol of the LATFIA trial (Laser Assisted Treatment of Fistula in Ano): a multicentre, prospective, randomized controlled trial comparing fistula-tract laser closure (FiLaC™) with rectal advancement flap for high trans-sphincteric fistulas. Anal fistula is one of the most common anal diseases, affecting between 1 and 3 per 10 000 people per year. Symptoms have a potentially severe effect on a patient's quality of life. Surgery is the mainstay of treatment, aiming to cure the fistula and preserve anal sphincter function. Rectal advancement flap (RAF) is currently the gold standard treatment but has recurrence rates varying between 20% and 50% and might lead to disturbance of continence. The aim of the trial described in this work is to discover if the minimally invasive fistula tract laser

Darvadstrocel (Alofisel) for complex perianal fistulae in Crohn's disease. A rash marketing authorisation decision Prescrire IN ENGLISH - Spotlight ''Darvadstrocel (Alofisel°) for complex perianal fistulae in Crohn's disease. A rash marketing authorisation decision'', 1 March 2020 {1}##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1}##LOC[OK]####LOC[Cancel]## Register online| Log in| My Prescrire * Testimonials * Prescrire events * A global network Offers * Subscribe now * Solidarity Subscription Rate * Subscribers: register online * Prescrire's other products * Free Special Edition * Sign up to receive the newsletter english.prescrire.org > Spotlight > 100 most recent > Darvadstrocel (Alofisel°) for complex perianal fistulae in Crohn's disease. A rash marketing authorisation decision